Latest Regulatory News

Janus Electric has landed further orders worth approximately A$1.6 million from its authorised California dealer, Electric Vehicle Choice, marking a significant step in its U.S. market expansion. The orders include conversion modules, batteries, and charging infrastructure, with shipment planned for mid-2026.

Cobre Limited has voluntarily suspended its ASX trading to finalise details of a significant acquisition and placement, with an announcement expected imminently.

Meteoric Resources has successfully commissioned its Mixed Rare Earth Carbonate pilot plant in Brazil, achieving strong recovery rates and production outputs that validate its processing approach and de-risk the Caldeira project.

DPM Metals Inc. delivered record revenues and earnings in 2025, driven by higher metal prices and stable production, while completing the strategic acquisition of Adriatic Metals plc, adding the Vareš polymetallic mine to its portfolio. The company outlines a robust three-year growth plan focused on expanding production and exploration.

ECS Botanics has partnered with Nimbus Health to distribute its medicinal cannabis products across Germany, marking its entry into Europe's largest cannabis market. The launch of the OzSun brand is set for April 2026, with premium Terphogz strains to follow later in the year.

Tartana Minerals has made significant strides in expanding its silver exploration footprint with uncontested progress on EPM 27220, covering historic high-grade silver mines. The company also restates a robust Nightflower Exploration Target and plans extensive drilling in 2026.

Element 25 Limited is making significant strides in its Butcherbird Expansion Project, targeting a manganese concentrate output of 1.1 million tonnes per annum with key contracts shortlisted and financing progressing.

Paradigm Biopharmaceuticals has published a pivotal study in PLOS ONE showing sustained pain relief and joint repair in dogs treated with pentosan polysulfate sodium, reinforcing its potential for human osteoarthritis therapy.

Revolution Private Credit Income Trust has successfully raised $60 million through a wholesale placement, strengthening its capacity to invest in senior secured loans and asset-backed securities across Australia and New Zealand.

Cyclopharm Limited has completed the initial phase of a $14 million share placement, issuing nearly 9.5 million shares at 95 cents each, with the remaining shares set for issuance later this month.

humm Group reports a $13.9 million statutory profit for 1H26, driven by commercial lending growth and strong consumer segment performance despite rising credit losses and regulatory costs.

Humm Group Limited reported a $13.9 million statutory profit for the half-year ended December 2025, despite increased credit losses and elevated costs. The company’s ongoing transformation and global expansion underpin cautious optimism for the year ahead.